Productivity Commission advocates change to compulsory licensing of patents
7 June 2013
compulsory licensing, Crown use, Productivity Commission, patents, patent reform
Read on
James Ellsmore
Farmer exhausts his options in dispute over patented seeds
27 May 2013
patent exhaustion monsanto bowman
Read on
Are your patents ready to jump the Raised Bar?
28 March 2013
Significant changes to Australian patent prosecution procedures come into effect on 15 April 2013
Read on
Blockbuster drug goes bust? The Federal Court finds three AstraZeneca patents relating to Crestor (rosuvastatin) invalid
7 March 2013
Justice Jagot of the Federal Court holds three patents relating to the blockbuster drug Crestor (rosuvastatin) invalid and liable to be revoked
Read on
Oh what a feeling! Jetstar disputes Toyota’s rights to register “jumping” trade marks
19 September 2012
It appears that Toyota may have got the jump on Jetstar by filing a series of trade mark applications to protect its well-known “Oh, what a feeling!” jump which has been used by the car maker since the 1980s to promote its vehicles.
Read on
King & Wood Mallesons releases its Review of Australia’s Patent Cases For 2011
1 June 2012
In what was a busy year for patent law in Australia, 2011 saw the Full Federal Court overturning an interlocutory injunction in the much publicised Apple v Samsung saga (relating to Samsung’s Galaxy Tab 10.1) while the Federal Court was busy handing down a number of other important decisions on infringement – including authorisation and indirect infringement, and invalidity – with significant developments in novelty and ‘whole of contents’ documents, as well as fair basis.
Read on
UPDATED: Raising the Bar Bill becomes law
18 April 2012
UPDATE: Further to our previous post on the passing of the Raising the Bar amendments, the IP Whiteboard team can confirm that the Intellectual Property Laws Amendment (Raising the Bar) Act was assented to by Australia’s Governor General on 15 April 2012.
Read on
Parties live to fight another day in gene patents battle
30 March 2012
On Monday, the United States Supreme Court set aside the Court of Appeals decision in Association for Molecular Pathology v Myriad Genetics (Myriad Genetics case), ordering the Court of Appeals to reconsider its finding that gene patents for the detection of inheritable breast cancer were valid in light of the Supreme Court’s subsequent decision in Mayo Collaborative Services v Prometheus Laboratories Inc (Prometheus Laboratories case) handed down last week.
Read on
Prometheus Laboratories receives a terminal diagnosis from the US Supreme Court
29 March 2012
The United States Supreme Court found last week that the claims of Prometheus’ diagnostic method patents were invalid.
Read on
Controversial licence granted over patented cancer drug
19 March 2012
In September last year we reported that the Indian pharmaceutical company Natco had applied for a compulsory licence to manufacture and sell (in India) a generic version of Bayer’s patented anti-cancer drug sorafenib (Nexavar).
Read on
Load More Posts